Researchers from WuXi-NextCode,
based in Shanghai, China, will sequence the genomes of 1000 cancer patients to
identify new cancer-causing mutations and make the resulting database freely
available to researchers. The
information could be used to develop new precision cancer treatment and make
them available to people worldwide. Doctors,
cancer specialists and surgeons in San Antonio will help collaborate by gather
tumor samples from patients with breast, lung, prostate, skin, colorectal,
uterine, pancreatic, ovarian, stomach, brain cancer and blood sample with
germline DNA, that does not carry mutation found in cancerous tissue. NextCode is a spinoff from deCODE genetic
based in Iceland where its technology was developed to handle analyzing and
storing whole genome data from 350,000 people and validating more than 40
million variants.
This is interesting and could be
useful for any of us who have plans to go into genetics or Oncology. We could help find cures for cancer and
NextCode would help with allowing everyone who uses it to share their findings
and collaborate with each other. I know
that WuXi PharmaTech, the company that purchased deCODE for $65 Million in
January, have a local lab in Philadelphia. I don’t think the local lab is part
of this program but I do know they are constantly looking for scientist for
their labs.
Tags: NextCode, deCODE, Cancer genome, open source sharing,
WuXi PharmaTech
This is very invteresting and could serve as great strides in the development of cancer research. This study could help treat many cancers as well as open up jobs for many people around the world. It'll be interesting to see how the results of these experiments play out.
ReplyDelete